TR200907915A2 - Pharmaceutical composition in dry powder form. - Google Patents

Pharmaceutical composition in dry powder form.

Info

Publication number
TR200907915A2
TR200907915A2 TR2009/07915A TR200907915A TR200907915A2 TR 200907915 A2 TR200907915 A2 TR 200907915A2 TR 2009/07915 A TR2009/07915 A TR 2009/07915A TR 200907915 A TR200907915 A TR 200907915A TR 200907915 A2 TR200907915 A2 TR 200907915A2
Authority
TR
Turkey
Prior art keywords
powder form
pharmaceutical composition
dry powder
agonists
pharmaceutical compositions
Prior art date
Application number
TR2009/07915A
Other languages
Turkish (tr)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2009/07915A priority Critical patent/TR200907915A2/en
Priority to PCT/TR2010/000207 priority patent/WO2011049538A2/en
Publication of TR200907915A2 publication Critical patent/TR200907915A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, ***e
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut buluş, solunum yolu rahatsızlıklarında kullanılmak üzere, p2-agonistleri ve antikolinerjik ilaçlardan oluşan, kum toz formundaki farmasötik kompozisyonlara ve bunları içeren blister formlarına ilişkindir.The present invention relates to pharmaceutical compositions in sand powder form and blister forms comprising p2-agonists and anticholinergic drugs for use in respiratory disorders.

TR2009/07915A 2009-10-20 2009-10-20 Pharmaceutical composition in dry powder form. TR200907915A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2009/07915A TR200907915A2 (en) 2009-10-20 2009-10-20 Pharmaceutical composition in dry powder form.
PCT/TR2010/000207 WO2011049538A2 (en) 2009-10-20 2010-10-20 Pharmaceutical composition in dry powder form

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2009/07915A TR200907915A2 (en) 2009-10-20 2009-10-20 Pharmaceutical composition in dry powder form.

Publications (1)

Publication Number Publication Date
TR200907915A2 true TR200907915A2 (en) 2011-05-23

Family

ID=43900868

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2009/07915A TR200907915A2 (en) 2009-10-20 2009-10-20 Pharmaceutical composition in dry powder form.

Country Status (2)

Country Link
TR (1) TR200907915A2 (en)
WO (1) WO2011049538A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102901821A (en) * 2012-09-27 2013-01-30 江苏维赛科技生物发展有限公司 Colloidal gold detection card for detecting adrenoreceptor stimulant and sample processing method

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9902689D0 (en) * 1999-02-08 1999-03-31 Novartis Ag Organic compounds
GB0009606D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic combinations
US20030018019A1 (en) * 2001-06-23 2003-01-23 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
AU2003250166A1 (en) 2002-07-25 2004-02-16 Glaxo Group Limited Medicament dispenser
EP1691783B1 (en) * 2003-12-03 2009-11-25 Boehringer Ingelheim International GmbH Pre-metered dry powder inhaler for moisture-sensitive medicaments
DE102004026515A1 (en) 2004-05-19 2005-12-15 Deutsches Zentrum für Luft- und Raumfahrt e.V. Ceramic armor plate, tank system and method of making a ceramic armor plate
GB0515584D0 (en) 2005-07-28 2005-09-07 Glaxo Group Ltd Medicament dispenser
AR058290A1 (en) 2005-12-12 2008-01-30 Glaxo Group Ltd MEDICINAL DISPENSER
TR200907238A2 (en) * 2009-09-23 2011-04-21 Bi̇lgi̇ç Mahmut Transport of the combination containing tiotropium in the blister.

Also Published As

Publication number Publication date
WO2011049538A3 (en) 2011-11-03
WO2011049538A2 (en) 2011-04-28

Similar Documents

Publication Publication Date Title
IL268756B (en) Piperazine-2,5-dione derivatives, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments
IL213517A (en) Sulfonamide derivatives, pharmaceutical compositions comprising them and uses thereof in the manufacture of medicaments
BR112015011036A2 (en) heterocyclic substituted 2-amino-quinazoline derivatives for the treatment of viral infections
IL233677A (en) Substituted benzisoxazole aminopyrazolo-pyrimidine compounds, pharmaceutical compositions comprising them and use of the compounds for the manufacture of medicaments
IL235020A0 (en) N-phenyl benzenesulfonamide derivatives, pharmaceutical compositions comprising them and their use in the manufacture of medicaments
IL222268A (en) Substituted pyrrolo-pyridines, pharmaceutical compositions comprising them, combined compositions comprising them and their use in the manufacture of medicaments
BR112015011112A2 (en) oligomeric compound, oligomer, pharmaceutical composition, use of the oligomeric compound, method of synthesis of an oligomeric compound and method of treating a disease.
BRPI0809667A2 (en) COMPOUND, MEDICINAL PRODUCT AND PHARMACEUTICAL COMPOSITION CONTAINING AND USE OF THE COMPOUND
IL223795A (en) Tetrahydro-pyrido-pyrimidine derivatives, process for their preparation, pharmaceutical compositions comprising them and use thereof in the manufacture of medicaments
CL2014000849A1 (en) Compounds derived from substituted benzylindazoles, bub1 kinase inhibitors; manufacturing procedure; pharmaceutical composition; pharmaceutical combination; and its use in the treatment of hyperproliferative diseases.
IT1403847B1 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING RIFAXIMINA AND THEIR USE.
IL236057B (en) 1,2,4-triazine-6-carboxamide derivatives and pharmaceutical compositions comprising them
HK1211021A1 (en) 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine derivatives, use thereof as medicaments, and pharmaceutical compositions 2--6--9--9h-
CY1113551T1 (en) Substituted nicotinamide compounds and their use in medicinal products
AR090975A1 (en) N-ETIL-4-HYDROXYL-1-METHYL-5- (METHYL (2,3,4,5,6-PENTAHYDROXIHEXIL) AMINO) -2-OXO-N-PHENYL-1,2-DIHYDROCHINOLINE-3-CARBOXAMIDE
IL213671A (en) Pharmaceutical compositions comprising aleglitazar, process for their manufacture and use thereof in the preparation of medicaments
EA201200485A1 (en) ORAL FALLING PHARMACEUTICAL DRUG FORM CONTAINING AIPIPRAZOL
EA201171414A1 (en) IAP FAMILY INHIBITORS
BR112013023575A2 (en) “octahydrothienoquinoline derivative, pharmaceutical composition comprising the derivative, and use thereof”
IL210975A (en) Enfumafungin derivatives, pharmaceutical compositions comprising them and use thereof for the preparation of medicaments for treating fungal infections
MX2014006201A (en) Imatinib solid dosage forms reconstituted just before use.
TR200909785A1 (en) Pharmaceutical compositions containing cefdinir as the active agent.
ATE481393T1 (en) NEW CYCLOALKYL-BENZOTHIADIAZINE DERIVATIVES, THEIR PRODUCTION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TR200907913A2 (en) Pharmaceutical composition in dry powder form for inhalation
EA201400444A1 (en) DERIVATIVES 2-OXOPYPERIDINYL